These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

255 related items for PubMed ID: 22033529

  • 1. Pirfenidone suppresses keloid fibroblast-embedded collagen gel contraction.
    Saito M, Yamazaki M, Maeda T, Matsumura H, Setoguchi Y, Tsuboi R.
    Arch Dermatol Res; 2012 Apr; 304(3):217-22. PubMed ID: 22033529
    [Abstract] [Full Text] [Related]

  • 2. Simvastatin inhibits transforming growth factor-β1-induced expression of type I collagen, CTGF, and α-SMA in keloid fibroblasts.
    Mun JH, Kim YM, Kim BS, Kim JH, Kim MB, Ko HC.
    Wound Repair Regen; 2014 Apr; 22(1):125-33. PubMed ID: 24471776
    [Abstract] [Full Text] [Related]

  • 3. Effects of pirfenidone on proliferation, migration, and collagen contraction of human Tenon's fibroblasts in vitro.
    Lin X, Yu M, Wu K, Yuan H, Zhong H.
    Invest Ophthalmol Vis Sci; 2009 Aug; 50(8):3763-70. PubMed ID: 19264889
    [Abstract] [Full Text] [Related]

  • 4. Pirfenidone inhibits the expression of HSP47 in TGF-beta1-stimulated human lung fibroblasts.
    Nakayama S, Mukae H, Sakamoto N, Kakugawa T, Yoshioka S, Soda H, Oku H, Urata Y, Kondo T, Kubota H, Nagata K, Kohno S.
    Life Sci; 2008 Jan 16; 82(3-4):210-7. PubMed ID: 18093617
    [Abstract] [Full Text] [Related]

  • 5. Troglitazone suppresses transforming growth factor-beta1-induced collagen type I expression in keloid fibroblasts.
    Zhang GY, Yi CG, Li X, Ma B, Li ZJ, Chen XL, Guo SZ, Gao WY.
    Br J Dermatol; 2009 Apr 16; 160(4):762-70. PubMed ID: 19120328
    [Abstract] [Full Text] [Related]

  • 6. Keloid-derived fibroblasts show increased secretion of factors involved in collagen turnover and depend on matrix metalloproteinase for migration.
    Fujiwara M, Muragaki Y, Ooshima A.
    Br J Dermatol; 2005 Aug 16; 153(2):295-300. PubMed ID: 16086739
    [Abstract] [Full Text] [Related]

  • 7. FK506 inhibits the enhancing effects of transforming growth factor (TGF)-β1 on collagen expression and TGF-β/Smad signalling in keloid fibroblasts: implication for new therapeutic approach.
    Wu CS, Wu PH, Fang AH, Lan CC.
    Br J Dermatol; 2012 Sep 16; 167(3):532-41. PubMed ID: 22540338
    [Abstract] [Full Text] [Related]

  • 8. SB-431542 inhibits TGF-beta-induced contraction of collagen gel by normal and keloid fibroblasts.
    Hasegawa T, Nakao A, Sumiyoshi K, Tsuchihashi H, Ogawa H.
    J Dermatol Sci; 2005 Jul 16; 39(1):33-8. PubMed ID: 15978417
    [Abstract] [Full Text] [Related]

  • 9. Pirfenidone attenuates lung fibrotic fibroblast responses to transforming growth factor-β1.
    Jin J, Togo S, Kadoya K, Tulafu M, Namba Y, Iwai M, Watanabe J, Nagahama K, Okabe T, Hidayat M, Kodama Y, Kitamura H, Ogura T, Kitamura N, Ikeo K, Sasaki S, Tominaga S, Takahashi K.
    Respir Res; 2019 Jun 11; 20(1):119. PubMed ID: 31185973
    [Abstract] [Full Text] [Related]

  • 10. [Effects of interferon-gamma on the transforming growth factor beta/Smad pathway in keloid-derived fibroblasts].
    Liu JQ, Hu DH, Zhang ZF, Guan H, She T, Zhang J, Bai XZ.
    Zhonghua Shao Shang Za Zhi; 2009 Dec 11; 25(6):454-9. PubMed ID: 20193171
    [Abstract] [Full Text] [Related]

  • 11. Pirfenidone prevents radiation-induced intestinal fibrosis in rats by inhibiting fibroblast proliferation and differentiation and suppressing the TGF-β1/Smad/CTGF signaling pathway.
    Sun YW, Zhang YY, Ke XJ, Wu XJ, Chen ZF, Chi P.
    Eur J Pharmacol; 2018 Mar 05; 822():199-206. PubMed ID: 29374548
    [Abstract] [Full Text] [Related]

  • 12. Antifibrotic effects of pirfenidone in rat proximal tubular epithelial cells.
    Takakura K, Tahara A, Sanagi M, Itoh H, Tomura Y.
    Ren Fail; 2012 Mar 05; 34(10):1309-16. PubMed ID: 23002925
    [Abstract] [Full Text] [Related]

  • 13. Anti-fibrotic action of pirfenidone in Dupuytren's disease-derived fibroblasts.
    Zhou C, Liu F, Gallo PH, Baratz ME, Kathju S, Satish L.
    BMC Musculoskelet Disord; 2016 Nov 11; 17(1):469. PubMed ID: 27835939
    [Abstract] [Full Text] [Related]

  • 14. Compound Astragalus and Salvia miltiorrhiza extract inhibits cell proliferation, invasion and collagen synthesis in keloid fibroblasts by mediating transforming growth factor-β / Smad pathway.
    He S, Yang Y, Liu X, Huang W, Zhang X, Yang S, Zhang X.
    Br J Dermatol; 2012 Mar 11; 166(3):564-74. PubMed ID: 21967214
    [Abstract] [Full Text] [Related]

  • 15. Heparin stimulates production of bFGF and TGF-beta 1 by human normal, keloid, and fetal dermal fibroblasts.
    Carroll LA, Koch RJ.
    Med Sci Monit; 2003 Mar 11; 9(3):BR97-108. PubMed ID: 12640331
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Halofuginone regulates keloid fibroblast fibrotic response to TGF-β induction.
    Marty P, Chatelain B, Lihoreau T, Tissot M, Dirand Z, Humbert P, Senez C, Secomandi E, Isidoro C, Rolin G.
    Biomed Pharmacother; 2021 Mar 11; 135():111182. PubMed ID: 33433355
    [Abstract] [Full Text] [Related]

  • 18. A novel truncated TGF-beta receptor II downregulates collagen synthesis and TGF-beta I secretion of keloid fibroblasts.
    Chu Y, Guo F, Li Y, Li X, Zhou T, Guo Y.
    Connect Tissue Res; 2008 Mar 11; 49(2):92-8. PubMed ID: 18382895
    [Abstract] [Full Text] [Related]

  • 19. Pirfenidone inhibits transforming growth factor β1-induced extracellular matrix production in nasal polyp-derived fibroblasts.
    Shin JM, Park JH, Park IH, Lee HM.
    Am J Rhinol Allergy; 2015 Mar 11; 29(6):408-13. PubMed ID: 26637578
    [Abstract] [Full Text] [Related]

  • 20. Upregulation of transforming growth factor-beta1 and vascular endothelial growth factor in cultured keloid fibroblasts: relevance to angiogenic activity.
    Fujiwara M, Muragaki Y, Ooshima A.
    Arch Dermatol Res; 2005 Oct 11; 297(4):161-9. PubMed ID: 16184401
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.